Table 2.
Secondary outcomes of interest
| Endpoint and definitions | Data source |
| Mortality outcomes | |
| Inpatient mortality | Hospital record |
| Dialysis outcomes | |
| Inpatient dialysis | Order entry system |
| Discharged on dialysis | Social work records |
| Renal failure outcomes | |
| Percent who progress to Stage 2 AKI | Laboratory values |
| Percent who progress to Stage 3 AKI | Laboratory values |
| Duration of AKI | Laboratory values |
| Readmission rate and costs | |
| 30-day readmission rate | Hospital record |
| Cost of index hospitalisation | Billing records |
| Individual ‘Best Practice’ outcomes (proportion achieved per patient in study arm during index hospitalisation) | |
| Contrast administration | Order entry system |
| Fluid administration | Order entry system |
| Aminoglycoside administration | Order entry system |
| NSAID administration/cessation | Order entry system |
| ACE inhibitor administration/cessation | Order entry system |
| Urinalysis order | Order entry system |
| Documentation of AKI | Postdischarge ICD-10 codes |
| Monitoring of creatinine | Order entry system |
| Monitoring of urine output | Hospital Record |
| Renal consult | Direct chart review |
| Provider awareness outcomes | |
| Chart documentation of AKI (by post discharge ICD-10 codes) | Billing records |
| Chart documentation of AKI (adjudicated) | Direct chart review |
ACE, angiotensin converting enzyme; AKI, acute kidney injury; NSAID, non-steroidal anti-inflammatory drug.